Showing results (31-40 of 2,411) with videos related to
Sort By:
Pageof 242
Journal of Public Health (Oxford, England)|January 14, 2020
The impact of pharmaceutical innovation on the burden of disease in Ireland, 2000-2015Frank R LichtenbergEconomics and Human Biology|September 24, 2025
The impact of biomedical innovation on cancer mortality in 37 countries, 2003-2017Frank R LichtenbergExpert Review of Pharmacoeconomics & Outcomes Research|April 29, 2026
The relationship between changes in prescription drug sales and changes in mortality and hospital utilization in Denmark, 2005-2019Frank R LichtenbergHealth Economics|May 14, 2021
Are drug prices subject to creative destruction? Evidence from the US, 1997-2017Frank R LichtenbergThe American Journal of Managed Care|February 11, 2005
The effect of access restrictions on the vintage of drugs used by Medicaid enrolleesFrank R LichtenbergForum for Health Economics & Policy|August 30, 2022
The Impact of Biopharmaceutical Innovation on Disability, Social Security Recipiency, and Use of Medical Care of U.S. Community Residents, 1998-2015Frank R LichtenbergThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 7, 2015
The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995-2012Frank R LichtenbergForum for Health Economics & Policy|April 25, 2019
The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects AnalysisFrank R LichtenbergThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2011
The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999-2007Frank R LichtenbergExpert Review of Pharmacoeconomics & Outcomes Research|January 8, 2020
How cost-effective are new cancer drugs in the U.S.?Frank R LichtenbergPageof 242